Pure Global
NCT06393530

Erector Spinae Plane Block for Cervical Spine Surgery

Erector Spinae Plane Block for Cervical Spine Surgery. A Prospective, Randomized, Double-blinded Clinical Trial.
Poznan University of Medical Sciences·Phase 4·ClinicalTrials.gov·drugNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Spine Fusion,Spine Disease,Spinal Disease
Drug/Device/Intervention
0.9%sodium chloride
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Poznan University of Medical Sciences
Location
Poznan, Poland
Timeline & enrollment
Phase
Phase 4
Start date
May 01, 2024
End date
Jun 30, 2025
Enrollment
60 participants
Primary outcome

first need of opiate

Summary

The study aims to assess the interfacial plane blocks' effect on pain level, course of
 postoperative rehabilitation, and anti-inflammatory analgesic effect.

ICD-10 classifications
Other fusion of spineOther diseases of spinal cordOther specified diseases of spinal cordSequelae of fracture of spineDisease of spinal cord, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06393530
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06393530 through Pure Global AI's free database. This Phase 4 trial is sponsored by Poznan University of Medical Sciences and is currently Not yet recruiting. The study focuses on Spine Fusion,Spine Disease,Spinal Disease. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.